p33ING1b stimulates the transcriptional activity of the estrogen receptor α via its activation function (AF) 2 domain

Journal of Steroid Biochemistry and Molecular Biology

Volumn 87, Issue 1, 2003, Pages 57-63

  Toyama, Tatsuya ^a   Iwase, Hirotaka ^a   Yamashita, Hiroko ^a   Hara, Yasuo ^a   Sugiura, Hiroshi ^a   Zhang, Zhenhuan ^a   Fukai, Ichiro ^a   Miura, Yutaka ^a   Riabowol, Karl ^b   Fujii, Yoshitaka ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

Cofactor; Estrogen receptor ; ING1b; p33ING1b

Indexed keywords

ESTROGEN RECEPTOR ALPHA; PROTEIN; PROTEIN P33; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL STRAIN COS7; CHROMATIN STRUCTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DELETION MUTANT; EXPRESSION VECTOR; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; NONHUMAN; PROTEIN DOMAIN; PROTEIN FUNCTION; REPORTER GENE; TRANSCRIPTION INITIATION; UTERINE CERVIX CARCINOMA;

MAMMALIA; VECTORS;

EID: 10744229379     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(03)00388-1     Document Type: Article

References (29)

1. R.B. Dickson, M.E. Lippman, Cellular and molecular biology, in: R.B. Dickson, M.E. Lippman (Eds.), Breast Cancer, Kluwer Academic Publishers, Norwell, 1998, pp. 119-165.
2. Onate S.A., Tsai S.Y., Tsai M.J., O'Malley B.W. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science. 270:1995;1354-1357.
3. Voegel J.J., Heine M.J., Zechel C., Chambon P., Gronemeyer H. TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors. EMBO J. 15:1996;3667-3675.
4. Kamei Y., Xu L., Heinzel T., Torchia J., Kurokawa R., Gloss B., Lin S.C., Heyman R.A., Rose D.W., Glass C.K., Rosenfeld M.G. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell. 85:1996;403-414.
5. Torchia J., Rose D.W., Inostroza J., Kamei Y., Westin S., Glass C.K., Rosenfeld M.G. The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function. Nature. 387:1997;677-684.
6. Chakravarti D., LaMorte V.J., Nelson M.C., Nakajima T., Schulman I.G., Juguilon H., Montminy M., Evans R.M. Role of CBP/P300 in nuclear receptor signalling. Nature. 383:1996;99-103.
7. Korzus E., Torchia J., Rose D.W., Xu L., Kurokawa R., McInerney E.M., Mullen T.M., Glass C.K., Rosenfeld M.G. Transcription factor-specific requirements for coactivators and their acetyltransferase functions. Science. 279:1998;703-707.
8. Garkavtsev I., Kazarov A., Gudkov A., Riabowol K. Suppression of the novel growth inhibitor p33ING1 promotes neoplastic transformation. Nat. Genet. 14:1996;415-420.
9. Toyama T., Iwase H., Watson P., Muzik H., Saettler E., Magliocco A., DiFrancesco L., Forsyth P., Garkavtsev I., Kobayashi S., Riabowol K. Suppression of ING1 expression in sporadic breast cancer. Oncogene. 18:1999;5187-5193.
10. X. Feng, Y. Hara, K. Riabowol, Different HATs of the ING1 gene family, Trends Cell Biol. (2002).
11. Cheung K.J. Jr., Li G. The tumor suppressor ING1: structure and function. Exp. Cell Res. 268:2001;1-6.
12. Ma D., Lawless D., Riabowol K. Correction and addition to ING1 sequences. Nat. Genet. 23:1999;373. (erratum for Garkavtsev et al., 1996).
13. Aasland R., Gibson T.J., Stewart A.F. The PHD finger: implications for chromatin-mediated transcriptional regulation. Trends Biochem. Sci. 20:1995;56-59.
14. Vieyra D., Toyama T., Hara Y., Boland D., Johnston R., Riabowol K. ING1 isoforms differentially affect apoptosis in a cell age-dependent manner. Cancer Res. 62:2002;4445-4452.
15. Vieyra D., Loewith R., Scott M., Bonnefin P., Boisvert F.M., Cheema P., Pastyryeva S., Meijer M., Johnston R.N., Bazett-Jones D.P., McMahon S., Cole M.D., Young D., Riabowol K. Human ING1 proteins differentially regulate histone acetylation. J. Biol. Chem. 277:2002;29832-29839.
16. Scott M., Boisvert F.M., Vieyra D., Johnston R.N., Bazett-Jones D.P., Riabowol K. UV induces nucleolar translocation of ING1 through two distinct nucleolar targeting sequences. Nucleic Acids Res. 29:2001;2052-2058.
17. Loewith R., Meijer M., Lees-Miller S.P., Riabowol K., Young D. Three yeast proteins related to the human candidate tumor suppressor p33(ING1) are associated with histone acetyltransferase activities. Mol. Cell. Biol. 20:2000;3807-3816.
18. Tora L., White J., Brou C., Tasset D., Webster N., Scheer E., Chambon P. The human estrogen receptor has two independent nonacidic transcriptional activation functions. Cell. 59:1989;477-487.
19. Cowley S.M., Parker M.G. A comparison of transcriptional activation by ER alpha and ER beta. J. Steroid Biochem. Mol. Biol. 69:1999;165-175.
20. Skowyra D., Zeremski M., Neznanov N., Li M., Choi Y., Uesugi M., Hauser C.A., Gu W., Gudkov A.V., Qin J. Differential association of products of alternative transcripts of the candidate tumor suppressor ING1 with the mSin3/HDAC1 transcriptional corepressor complex. J. Biol. Chem. 276:2001;8734-8739.
21. Kuzmichev A., Zhang Y., Erdjument-Bromage H., Tempst P., Reinberg D. Role of the Sin3-histone deacetylase complex in growth regulation by the candidate tumor suppressor p33(ING1). Mol. Cell. Biol. 22:2002;835-848.
22. Howell A. Preliminary experience with pure antiestrogens. Clin. Cancer Res. 7:2001;4369s-4375s. discussion 4411s-4412s.
23. McGuire W.L. Steroid hormone receptors in breast cancer treatment strategy. Recent Prog. Horm. Res. 36:1980;135-156.
24. Shibata H., Spencer T.E., Onate S.A., Jenster G., Tsai S.Y., Tsai M.J., O'Malley B.W. Role of co-activators and co-repressors in the mechanism of steroid/thyroid receptor action. Recent Prog. Horm. Res. 52:1997;141-164. discussion 164-145.
25. Torchia J., Glass C., Rosenfeld M.G. Co-activators and co-repressors in the integration of transcriptional responses. Curr. Opin. Cell Biol. 10:1998;373-383.
26. Berns E.M., van Staveren I.L., Klijn J.G., Foekens J.A. Predictive value of SRC-1 for tamoxifen response of recurrent breast cancer. Breast Cancer Res. Treat. 48:1998;87-92.
27. Bautista S., Valles H., Walker R.L., Anzick S., Zeillinger R., Meltzer P., Theillet C. In breast cancer, amplification of the steroid receptor coactivator gene AIB1 is correlated with estrogen and progesterone receptor positivity. Clin. Cancer Res. 4:1998;2925-2929.
28. Anzick S.L., Kononen J., Walker R.L., Azorsa D.O., Tanner M.M., Guan X.Y., Sauter G., Kallioniemi O.P., Trent J.M., Meltzer P.S. AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science. 277:1997;965-968.
29. Lavinsky R.M., Jepsen K., Heinzel T., Torchia J., Mullen T.M., Schiff R., Del-Rio A.L., Ricote M., Ngo S., Gemsch J., Hilsenbeck S.G., Osborne C.K., Glass C.K., Rosenfeld M.G., Rose D.W. Diverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes. Proc. Natl. Acad. Sci. U.S.A. 95:1998;2920-2925.